316 related articles for article (PubMed ID: 26926077)
1. Interaction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer.
Huang L; Yu Z; Zhang Z; Ma W; Song S; Huang G
Sci Rep; 2016 Mar; 6():22449. PubMed ID: 26926077
[TBL] [Abstract][Full Text] [Related]
2. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
[TBL] [Abstract][Full Text] [Related]
3. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways.
Deleault KM; Skinner SJ; Brooks SA
Mol Immunol; 2008 Jan; 45(1):13-24. PubMed ID: 17606294
[TBL] [Abstract][Full Text] [Related]
4. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways.
Brook M; Tchen CR; Santalucia T; McIlrath J; Arthur JS; Saklatvala J; Clark AR
Mol Cell Biol; 2006 Mar; 26(6):2408-18. PubMed ID: 16508015
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
[TBL] [Abstract][Full Text] [Related]
6. PKM2 phosphorylates MLC2 and regulates cytokinesis of tumour cells.
Jiang Y; Wang Y; Wang T; Hawke DH; Zheng Y; Li X; Zhou Q; Majumder S; Bi E; Liu DX; Huang S; Lu Z
Nat Commun; 2014 Nov; 5():5566. PubMed ID: 25412762
[TBL] [Abstract][Full Text] [Related]
7. PKM2 gene regulates the behavior of pancreatic cancer cells via mitogen-activated protein kinase pathways.
Feng J; Ma T; Ge Z; Lin J; Ding W; Chen H; Zhu W; Zhou S; Tan Y
Mol Med Rep; 2015 Mar; 11(3):2111-7. PubMed ID: 25411978
[TBL] [Abstract][Full Text] [Related]
8. Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.
Bourcier C; Griseri P; Grépin R; Bertolotto C; Mazure N; Pagès G
Am J Physiol Cell Physiol; 2011 Sep; 301(3):C609-18. PubMed ID: 21593445
[TBL] [Abstract][Full Text] [Related]
9. CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.
Shang Y; He J; Wang Y; Feng Q; Zhang Y; Guo J; Li J; Li S; Wang Y; Yan G; Ren F; Shi Y; Xu J; Zeps N; Zhai Y; He D; Chang Z
Oncogene; 2017 Jul; 36(29):4191-4200. PubMed ID: 28346425
[TBL] [Abstract][Full Text] [Related]
10. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells.
Yu Z; Huang L; Qiao P; Jiang A; Wang L; Yang T; Tang S; Zhang W; Ren C
Biochem Biophys Res Commun; 2016 May; 473(4):953-958. PubMed ID: 27045080
[TBL] [Abstract][Full Text] [Related]
11. p38 MAPK/PP2Acα/TTP pathway on the connection of TNF-α and caspases activation on hydroquinone-induced apoptosis.
Liu WH; Chou WM; Chang LS
Carcinogenesis; 2013 Apr; 34(4):818-27. PubMed ID: 23288922
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate kinase M2 interacts with DNA damage-binding protein 2 and reduces cell survival upon UV irradiation.
Xie X; Wang M; Mei J; Hu F; Ding F; Lv L
Biochem Biophys Res Commun; 2015 Nov; 467(2):427-33. PubMed ID: 26410533
[TBL] [Abstract][Full Text] [Related]
13. Lack of Evidence for PKM2 Protein Kinase Activity.
Hosios AM; Fiske BP; Gui DY; Vander Heiden MG
Mol Cell; 2015 Sep; 59(5):850-7. PubMed ID: 26300261
[TBL] [Abstract][Full Text] [Related]
14. The Conserved CNOT1 Interaction Motif of Tristetraprolin Regulates ARE-mRNA Decay Independently of the p38 MAPK-MK2 Kinase Pathway.
Carreño A; Lykke-Andersen J
Mol Cell Biol; 2022 Sep; 42(9):e0005522. PubMed ID: 35920669
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
[TBL] [Abstract][Full Text] [Related]
16. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
[TBL] [Abstract][Full Text] [Related]
17. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
[TBL] [Abstract][Full Text] [Related]
19. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
